Abcur AB is a Swedish based pharmaceutical company focusing on development, registration and marketing of specialized pharmaceutical products. Our strive is to make necessary pharmaceutical products available in the Nordic area. This is done by a close cooperation with the medical care.
Abcur AB was acquired by Amdipharm Mercury - AMCo. on December 06, 2013.
Join Mergr to view all 177 acquisitions of life science companies in 2013, including 20 acquisitions by private equity firms, and 157 by strategics.
Out of 60 sectors in the Mergr database, life science ranked 10 in number of deals in 2013. The largest life science acquisition in 2013 was Onyx Pharmaceuticals - which was acquired by Amgen for $10.4B.
Join Mergr to view this profile - and discover more life science acquisitions of companies like Abcur AB.
No obligation. Cancel anytime.